MAZE (Maze Therapeutics) Construction In Progress: $0.00 Mil (As of Mar. 2026)


MAZE Maze Therapeutics Inc MAZE
14 GF Score
Price $28.44
! 2 Warning Signs
View Full Analysis

What is Maze Therapeutics Construction In Progress?

Maze Therapeutics MAZE +5.18% 14 Construction In Progress is $0.00 Mil as of Mar. 2026. GuruFocus rates MAZE with a GF Score™ of 14/100. The stock has 2 warning signs investors should review.

Maze Therapeutics's quarterly construction in progress increased from Sep. 2025 ($0.00 Mil) to Dec. 2025 ($0.04 Mil) but then declined from Dec. 2025 ($0.04 Mil) to Mar. 2026 ($0.00 Mil).

Maze Therapeutics's annual construction in progress declined from Dec. 2023 ($0.06 Mil) to Dec. 2024 ($0.03 Mil) but then increased from Dec. 2024 ($0.03 Mil) to Dec. 2025 ($0.04 Mil).

Maze Therapeutics Construction In Progress Historical Data

* Premium members only.

The historical data trend for Maze Therapeutics's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Maze Therapeutics Construction In Progress Chart

Maze Therapeutics Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Construction In Progress
0.00 0.06 0.03 0.04

Maze Therapeutics Quarterly Data
Dec22 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.04 0.00
MAZE
14GF Score
Maze Therapeutics Inc MAZE
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Maze Therapeutics Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of $0.00 Mil mean?
Maze Therapeutics (MAZE) has a Construction In Progress of $0.00 Mil as of Mar. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Maze Therapeutics and its competitors.
Is Maze Therapeutics' Construction In Progress too high?
Maze Therapeutics' current Construction In Progress is $0.00 Mil. Overall, Maze Therapeutics has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Maze Therapeutics' Construction In Progress compare to FTRE and ARDX?
Maze Therapeutics' Construction In Progress of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Biotechnology company?
A good Construction In Progress depends on the Biotechnology industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Maze Therapeutics and its competitors. Maze Therapeutics's current Construction In Progress is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Maze Therapeutics stock overvalued right now?
Maze Therapeutics (MAZE) has a current Construction In Progress of $0.00 Mil. The current Construction In Progress is $0.00 Mil. Maze Therapeutics' overall GF Score™ is 14/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Maze Therapeutics (MAZE), the current Construction In Progress is $0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Maze Therapeutics Business Description

Address 171 Oyster Point boulevard, Suite 300, South San Francisco, CA, USA, 94080
Maze Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small-molecule precision medicines for patients living with renal, cardiovascular, and related metabolic, or CVRM, diseases, including obesity. The company is advancing a pipeline using its Compass platform, which allows the company to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process it refers to as variant functionalization. It is currently advancing two programs, MZE829 and MZE782, each of which represents a novel precision medicine-based approach for chronic kidney disease, or CKD.
14GF Score

Get the complete analysis for MAZE

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$28.44
Price